Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria

Supplementary material for article published in Clinical Experimental Allergy (Baumann et al): Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Simon Francis Thomsen
Format: Dataset
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Supplementary material for article published in Clinical Experimental Allergy (Baumann et al): Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria
DOI:10.17632/43y6kcf6pg.1